Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
BioNumerik Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00097903
First received: December 1, 2004
Last updated: October 22, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)